{"id":229452,"date":"2023-06-14T10:22:34","date_gmt":"2023-06-14T10:22:34","guid":{"rendered":"https:\/\/www.healthbenefitstimes.com\/glossary\/?p=229452"},"modified":"2023-06-14T10:22:34","modified_gmt":"2023-06-14T10:22:34","slug":"lues-maligna","status":"publish","type":"post","link":"https:\/\/www.healthbenefitstimes.com\/glossary\/lues-maligna\/","title":{"rendered":"Lues maligna"},"content":{"rendered":"
\n
\n
\n
\n
\n
\n

In the context of medical conditions, there are instances where individuals with secondary syphilis, particularly those who are HIV-positive, may experience the development of ulcerated and necrotic skin tissue. These areas of skin damage and decay represent a manifestation of secondary syphilis and commonly occur in individuals with concurrent HIV infection. Recognizing the occurrence of these ulcerated and dying skin areas aids in understanding the complexities of syphilis and its impact on individuals with compromised immune systems.<\/p>\n

\n

 <\/p>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

In the context of medical conditions, there are instances where individuals with secondary syphilis, particularly those who are HIV-positive, may experience the development of ulcerated and necrotic skin tissue. These areas of skin damage and decay represent a manifestation of secondary syphilis and commonly occur in individuals with concurrent HIV infection. Recognizing the occurrence of […]<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":["post-229452","post","type-post","status-publish","format-standard","hentry","category-a"],"yoast_head":"\nLues maligna - Definition of Lues maligna<\/title>\n<meta name=\"description\" content=\"In the context of medical conditions, there are instances where individuals with secondary syphilis, particularly those who are HIV-positive, may experience the development of ulcerated and necrotic skin tissue. These areas of skin damage and decay represent a manifestation of secondary syphilis and commonly occur in individuals with concurrent HIV infection. Recognizing the occurrence of these ulcerated and dying skin areas aids in understanding the complexities of syphilis and its impact on individuals with compromised immune systems.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.healthbenefitstimes.com\/glossary\/lues-maligna\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Lues maligna - Definition of Lues maligna\" \/>\n<meta property=\"og:description\" content=\"In the context of medical conditions, there are instances where individuals with secondary syphilis, particularly those who are HIV-positive, may experience the development of ulcerated and necrotic skin tissue. These areas of skin damage and decay represent a manifestation of secondary syphilis and commonly occur in individuals with concurrent HIV infection. Recognizing the occurrence of these ulcerated and dying skin areas aids in understanding the complexities of syphilis and its impact on individuals with compromised immune systems.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.healthbenefitstimes.com\/glossary\/lues-maligna\/\" \/>\n<meta property=\"og:site_name\" content=\"Glossary\" \/>\n<meta property=\"article:published_time\" content=\"2023-06-14T10:22:34+00:00\" \/>\n<meta name=\"author\" content=\"Glossary\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Glossary\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/lues-maligna\/\",\"url\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/lues-maligna\/\",\"name\":\"Lues maligna - Definition of Lues maligna\",\"isPartOf\":{\"@id\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/#website\"},\"datePublished\":\"2023-06-14T10:22:34+00:00\",\"dateModified\":\"2023-06-14T10:22:34+00:00\",\"author\":{\"@id\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/#\/schema\/person\/ccfef987a4882e6356ae6d77d33e74c5\"},\"description\":\"In the context of medical conditions, there are instances where individuals with secondary syphilis, particularly those who are HIV-positive, may experience the development of ulcerated and necrotic skin tissue. These areas of skin damage and decay represent a manifestation of secondary syphilis and commonly occur in individuals with concurrent HIV infection. Recognizing the occurrence of these ulcerated and dying skin areas aids in understanding the complexities of syphilis and its impact on individuals with compromised immune systems.\",\"breadcrumb\":{\"@id\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/lues-maligna\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.healthbenefitstimes.com\/glossary\/lues-maligna\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/lues-maligna\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Lues maligna\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/#website\",\"url\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/\",\"name\":\"Glossary\",\"description\":\"Difinitions\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/#\/schema\/person\/ccfef987a4882e6356ae6d77d33e74c5\",\"name\":\"Glossary\",\"url\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/author\/adminglossary\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Lues maligna - Definition of Lues maligna","description":"In the context of medical conditions, there are instances where individuals with secondary syphilis, particularly those who are HIV-positive, may experience the development of ulcerated and necrotic skin tissue. These areas of skin damage and decay represent a manifestation of secondary syphilis and commonly occur in individuals with concurrent HIV infection. Recognizing the occurrence of these ulcerated and dying skin areas aids in understanding the complexities of syphilis and its impact on individuals with compromised immune systems.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.healthbenefitstimes.com\/glossary\/lues-maligna\/","og_locale":"en_US","og_type":"article","og_title":"Lues maligna - Definition of Lues maligna","og_description":"In the context of medical conditions, there are instances where individuals with secondary syphilis, particularly those who are HIV-positive, may experience the development of ulcerated and necrotic skin tissue. These areas of skin damage and decay represent a manifestation of secondary syphilis and commonly occur in individuals with concurrent HIV infection. Recognizing the occurrence of these ulcerated and dying skin areas aids in understanding the complexities of syphilis and its impact on individuals with compromised immune systems.","og_url":"https:\/\/www.healthbenefitstimes.com\/glossary\/lues-maligna\/","og_site_name":"Glossary","article_published_time":"2023-06-14T10:22:34+00:00","author":"Glossary","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Glossary","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.healthbenefitstimes.com\/glossary\/lues-maligna\/","url":"https:\/\/www.healthbenefitstimes.com\/glossary\/lues-maligna\/","name":"Lues maligna - Definition of Lues maligna","isPartOf":{"@id":"https:\/\/www.healthbenefitstimes.com\/glossary\/#website"},"datePublished":"2023-06-14T10:22:34+00:00","dateModified":"2023-06-14T10:22:34+00:00","author":{"@id":"https:\/\/www.healthbenefitstimes.com\/glossary\/#\/schema\/person\/ccfef987a4882e6356ae6d77d33e74c5"},"description":"In the context of medical conditions, there are instances where individuals with secondary syphilis, particularly those who are HIV-positive, may experience the development of ulcerated and necrotic skin tissue. These areas of skin damage and decay represent a manifestation of secondary syphilis and commonly occur in individuals with concurrent HIV infection. Recognizing the occurrence of these ulcerated and dying skin areas aids in understanding the complexities of syphilis and its impact on individuals with compromised immune systems.","breadcrumb":{"@id":"https:\/\/www.healthbenefitstimes.com\/glossary\/lues-maligna\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.healthbenefitstimes.com\/glossary\/lues-maligna\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.healthbenefitstimes.com\/glossary\/lues-maligna\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.healthbenefitstimes.com\/glossary\/"},{"@type":"ListItem","position":2,"name":"Lues maligna"}]},{"@type":"WebSite","@id":"https:\/\/www.healthbenefitstimes.com\/glossary\/#website","url":"https:\/\/www.healthbenefitstimes.com\/glossary\/","name":"Glossary","description":"Difinitions","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.healthbenefitstimes.com\/glossary\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.healthbenefitstimes.com\/glossary\/#\/schema\/person\/ccfef987a4882e6356ae6d77d33e74c5","name":"Glossary","url":"https:\/\/www.healthbenefitstimes.com\/glossary\/author\/adminglossary\/"}]}},"_links":{"self":[{"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/posts\/229452","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/comments?post=229452"}],"version-history":[{"count":1,"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/posts\/229452\/revisions"}],"predecessor-version":[{"id":229453,"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/posts\/229452\/revisions\/229453"}],"wp:attachment":[{"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/media?parent=229452"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/categories?post=229452"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/tags?post=229452"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}